Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France.
Frequently asked questions
What sector does Safe Orthopaedics SA (ALSAF) operate in?
Safe Orthopaedics SA belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Safe Orthopaedics SA (ALSAF) current stock price?
As of the latest data, Safe Orthopaedics SA stock price is €0.64, with a previous close of €0.64.
What is Safe Orthopaedics SA (ALSAF) current market capitalization?
Safe Orthopaedics SA market cap is approximately 127.51 thousand.
What is Safe Orthopaedics SA (ALSAF) Earnings Per Share (EPS)?
The trailing EPS is -€0.02.
Does Safe Orthopaedics SA (ALSAF) pay dividends?
No. Safe Orthopaedics SA does not pay a dividend.
What is Safe Orthopaedics SA (ALSAF) beta (volatility) score?
Safe Orthopaedics SA has a beta of -0.857, indicating lower volatility than the overall market.
